3 Einträge gefunden

1. Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity.

   1. Bacher, Ulrike
   2. Schnittger, Susanne
   3. Macijewski, Katja
   4. Grossmann, Vera
   5. Kohlmann, Alexander
   6. Alpermann, Tamara
   7. Kowarsch, Andreas

   2012 - Forschungsinformationssystem des UKE
2. Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1).

   1. Falini, Brunangelo
   2. Macijewski, Katja
   3. Weiss, Tamara
   4. Bacher, Ulrike
   5. Schnittger, Susanne
   6. Kern, Wolfgang
   7. Kohlmann, Alexander

   2010 - Forschungsinformationssystem des UKE
3. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC).

   1. Miesner, Miriam
   2. Haferlach, Claudia
   3. Bacher, Ulrike
   4. Weiss, Tamara
   5. Macijewski, Katja
   6. Kohlmann, Alexander
   7. Klein, Hans-Ulrich

   2010 - Forschungsinformationssystem des UKE